Skip to main content


ADAPTABLE (Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness) is a study comparing the effectiveness of two daily doses of aspirin widely used to prevent heart attacks and strokes in individuals living with heart disease.

ADAPTABLE spans the U.S. and is the first demonstration project to be conducted through PCORnet, the National Patient-Centered Clinical Research Network. PCORnet is a PCORI-funded initiative designed to improve the nation’s capacity to conduct comparative clinical effectiveness research.

In Chicagoland, ADAPTABLE is an offshoot of CAPriCORN.  We’re implementing a recruitment strategy that engages patients during office visits as well as in non-clinical settings in underserved communities. Community recruitment partners include Sinai Urban Health Institute and Pastors 4 PCOR.

For more information, visit

Principal Investigator:
Abel Kho

ADAPTABLE is funded through a Patient-Centered Outcomes Research Institute (PCORI) Award (Contract Number: ASP-1502-27079).

Chicago Community Trust
Duke University
Pastors 4 PCOR
Sinai Urban Health Institute

Follow CHIP on LinkedIn